Conn’s Current Therapy 2012, by Drs. Edward T. Bope and Rick D. Kellerman, offers you expert guidance on the latest therapeutic options for common and not-so-common health concerns. Hundreds of international contributors provide evidence-based management options to help you make more effective diagnoses and achieve the best outcomes. Find what you need quickly and easily with a totally reworked organization of topics, and keep current with updated material throughout, including brand-new chapters on fatigue and migraines. This practical guide is your ideal way to learn and apply the latest, most effective therapeutic approaches. Gain the most effective results for your patients with quick, easy access to the latest evidence-based treatments and therapies. Apply the proven treatment strategies of hundreds of top experts in your field. Optimize reimbursement using the latest ICD-9 codes. Easily reference in-depth topics such as metabolic conditions, digestive diseases, skin disorders, and more with a reworked organization that lets you look up specific illnesses and find all the information you need in one place. Get quick access to critical information with the new "Current Diagnosis" and "Current Therapy" boxes at the beginning of each chapter. Broaden your range of treatment options for fatigue and migraines with the aid of two brand-new chapters. Keep up to date with recently approved and soon-to-be discovered drugs.
Fluorescein (Fluorets) should be used to identify corneal injury. Chemical burns to the eyes should be rinsed with copious amounts of saline. Burns Figure 2. Lund–Browder classification of burn size. 2.5 2.5 1.
Harper SL, Chorich LJ, Foster CS. Diagnosis of uveitis. In: Foster CS, Vitale A, editors. Diagnosis and Treatment of Uveitis. Philadelphia: WB Saunders; 2002. p. 79–97. Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of ...
In Swerdlow S, Campo E, Lee Harris N, et al, editors: WHO Classification of Tumors of Hematopoietic ... Cutler CS, Lee SJ, Greenberg P, et al: A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic ...
In: Swerdlow S, Campo E, Lee Harris N, et al., WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC; 2008. p. 88–103. Cutler CS, Lee SJ, Greenberg P, et al. A decision analysis of allogeneic ...
In: Swerdlow S, Campo E, Lee Harris N, et al., WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. 4th ed. ... Greenberg PL. The smoldering myeloid leukemic states: Clinical and biologic features. Blood 1983;61:1035–44.
Corbel MJ: Brucellosis in humans and animals, Geneva, 2006, World Health Organization. Dokuzoguz B, Nurcan Baykam N: Brucellosis. In Bope ET, Kellerman RD, Rakel RE, editors: Conn's Current Therapy 2011, Philadelphia, 2011, Saunders, ...
Fogel J, Eaton WW, Ford DE: Minor depression as a predictor of the first onset of major depressive disorder over a 15-year follow-up, Acta Psychiatr Scand 113 (1):36–43, 2006. Frank E, Kupfer DJ, Thase ME, et al: Two-year outcomes for ...
Dow J, Glesbrecht GG, Danzl DF, et al: Wilderness Medical Society Clinical Practice Guidelines for the out- of- hospital evaluation and treatment of accidental hypo- thermia: 2019 update, Wilderness Environ Med 30(4):S47–S69, 2019.
Hamborsky J, Kroger A, Wolfe S, eds. Washington, DC: Public Health Foundation, pp 325–340, 2015. Lambert N, Strebel P, Orenstein W, et al: Rubella, Lancet 385(9984):2297–2307, 2015. Papania M, Wallace G, Rota P, et al: Elimination of ...
In Bope ET, Kellerman RD, Rakel RE, editors: Conn's Current Therapy 2011, Philadelphia, 2011, Saunders, pp • Hematologic complications: Aspartate aminotransferase (AST) 74–78. Gür A, Geyik MF, Dikici B, et al: Complications of ...